Comparative analysis of vaspin in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women

Endocrine

Volumn 48, Issue 2, 2015, Pages 533-540

  Jia, Xiaojiao ^a,b   Wang, Shuyi ^b   Ma, Ning ^b   Li, Xiaojing ^b   Guo, Likui ^b   Liu, Xiaoli ^b   Dong, Tao ^b   Liu, Yali ^b   Lu, Qiang ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b FIRST HOSPITAL OF QINHUANGDAO   (China)

Author keywords

Adipokines; Gestational diabetes mellitus; Homeostatic model assessment insulin resistance; Vaspin

Indexed keywords

ADIPONECTIN; LEPTIN; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN;

ADULT; BLOOD; COMPARATIVE STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; PHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS;

ADIPONECTIN; ADULT; DIABETES, GESTATIONAL; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; PREGNANCY; SERPINS;

EID: 84935030971     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0318-7     Document Type: Article

References (43)

1. L. Bellamy, J.P. Casas, A.D. Hingorani, D. Williams, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373, 1773–1779 (2009)
2. P. Kalra, C.P. Kachhwaha, H.V. Singh, Prevalence of gestational diabetes mellitus and its outcome in western Rajasthan. Indian J. Endocrinol. Metab. 17, 677–680 (2013)
3. D. Dabelea, J.K. Snell-Bergeon, C.L. Hartsfield, K.J. Bischoff, R.F. Hamman, R.S. McDuffie, Kaiser Permanente of Colorado GDM Screening Program: increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28, 579–584 (2005)
4. L.A. Barbour, C.E. McCurdy, T.L. Hernandez, J.P. Kirwan, P.M. Catalano, J.E. Friedman, Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30, S112–S119 (2007)
5. A. Lapolla, M.G. Dalfrà, G. Mello, E. Parretti, R. Cioni, C. Marzari, M. Masin, A. Ognibene, G. Messeri, D. Fedele, A. Mari, G. Pacini, Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy. J. Clin. Endocrinol. Metab. 93, 876–880 (2008)
6. M. Blüher, A. Rudich, N. Klöting, R. Golan, Y. Henkin, E. Rubin, D. Schwarzfuchs, Y. Gepner, M.J. Stampfer, M. Fiedler, J. Thiery, M. Stumvoll, I. Shai, Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 35, 342–349 (2012)
7. Z. Goktas, N. Moustaid-Moussa, C.L. Shen, M. Boylan, H. Mo, S. Wang, Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front. Endocrinol. (Lausanne) 4, 69 (2013)
8. K. Miehle, H. Stepan, M. Fasshauer, Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin. Endocrinol. (Oxf). 76, 2–11 (2012)
9. R. Retnakaran, A.J. Hanley, N. Raif, P.W. Connelly, M. Sermer, B. Zinman, Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 27, 799–800 (2004)
10. D. Cortelazzi, S. Corbetta, S. Ronzoni, F. Pelle, A. Marconi, V. Cozzi, I. Cetin, R. Cortelazzi, P. Beck-Peccoz, A. Spada, Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin. Endocrinol. (Oxf). 66, 447–453 (2007)
11. K.Y. Lain, A.R. Daftary, R.B. Ness, J.M. Roberts, First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin. Endocrinol. (Oxf). 69, 407–411 (2008)
12. K. Rabe, M. Lehrke, K.G. Parhofer, U.C. Broedl, Adipokines and insulin resistance. Mol. Med. 14, 741–751 (2008)
13. G. Murdolo, M. Piroddi, F. Luchetti, C. Tortoioli, B. Canonico, C. Zerbinati, F. Galli, L. Iuliano, Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance. Biochimie 95, 585–594 (2013)
14. K. Bergmann, G. Sypniewska, Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? Clin. Chem. Lab. Med. 51, 177–185 (2013)
15. M. Blüher, Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 41, 176–182 (2012)
16. B.S. Youn, N. Klöting, J. Kratzsch, N. Lee, J.W. Park, E.S. Song, K. Ruschke, A. Oberbach, M. Fasshauer, M. Stumvoll, M. Blüher, Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57, 372–377 (2008)
17. B.K. Tan, D. Heutling, J. Chen, S. Farhatullah, R. Adya, S.D. Keay, C.R. Kennedy, H. Lehnert, H.S. Randeva, Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57, 1501–1507 (2008)
18. E. Herrera, H. Ortega-Senovilla, Disturbances in lipid metabolism in diabetic pregnancy—are these the cause of the problem? Best. Pract. Res. Clin. Endocrinol. Metab. 24, 515–525 (2010)
19. S.H. Choi, S.H. Kwak, Y. Lee, M.K. Moon, S. Lim, Y.J. Park, H.C. Jang, M.S. Kim, Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin. Endocrinol. (Oxf). 75, 628–635 (2011)
20. H.S. Cura, H.H. Ozdemir, C.F. Demir, S. Bulut, N. Ilhan, M.F. Inci, Investigation of vaspin level in patients with acute ischemic stroke. J. Stroke Cerebrovasc. Dis. 23, 453–456 (2014)
21. C. von Loeffelholz, M. Möhlig, A.M. Arafat, F. Isken, J. Spranger, K. Mai, H.S. Randeva, A.F. Pfeiffer, M.O. Weickert, Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur. J. Endocrinol. 162, 507–513 (2010)
22. S. Akbarzadeh, I. Nabipour, S.M. Jafari, A. Movahed, N. Motamed, M. Assadi, N. Hajian, Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 95, 132–138 (2012)
23. A. Gkiomisi, K.G. Makedou, A.D. Anastasilakis, S.A. Polyzos, A. Kourtis, S. Gerou, E. Gavana, T. Dagklis, D. Rousso, C. Giannoulis, Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum. Cytokine 61, 127–132 (2013)
24. H. Stepan, S. Kralisch, K. Klostermann, S. Schrey, C. Reisenbüchler, M. Verlohren, H.J. Verlohren, K. Drynda, M. Blüher, M. Stumvoll, J. Kratzsch, P. Kovacs, M. Fasshauer, Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 59, 1054–1056 (2010)
25. K. Li, L. Li, M. Yang, H. Liu, D. Liu, H. Yang, G. Boden, G. Yang, Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity. Eur. J. Endocrinol. 164, 905–910 (2011)
26. S. Teshigawara, J. Wada, K. Hida, A. Nakatsuka, J. Eguchi, K. Murakami, M. Kanzaki, K. Inoue, T. Terami, A. Katayama, I. Iseda, Y. Matsushita, N. Miyatake, J.F. McDonald, K. Hotta, H. Makino, Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J. Clin. Endocrinol. Metab. 97, E1202–E1207 (2012)
27. HAPO Study Cooperative Research Group, B.E. Metzger, L.P. Lowe, A.R. Dyer, E.R. Trimble, U. Chaovarindr, D.R. Coustan, D.R. Hadden, D.R. McCance, M. Hod, H.D. McIntyre, J.J. Oats, B. Persson, M.S. Rogers, D.A. Sacks, Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358, 1991–2002 (2008)
28. H.M. Chang, H.J. Lee, H.S. Park, J.H. Kang, K.S. Kim, Y.S. Song, Y.J. Jang, Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity 18, 2105–2110 (2010)
29. K. Hida, J. Wada, J. Eguchi, H. Zhang, M. Baba, A. Seida, I. Hashimoto, T. Okada, A. Yasuhara, A. Nakatsuka, K. Shikata, S. Hourai, J. Futami, E. Watanabe, Y. Matsuki, R. Hiramatsu, S. Akagi, H. Makino, Y.S. Kanwar, Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. USA 102, 10610–10615 (2005)
30. M.M. Roca-Rodríguez, C. López-Tinoco, A. Fernández-Deudero, M. Murri, M.V. García-Palacios, M.A. García-Valero, F.J. Tinahones-Madueño, M. Aguilar-Diosdado, Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus. Diabetes Metab. Res. Rev. 28, 542–548 (2012)
31. N. Klöting, P. Kovacs, M. Kern, J.T. Heiker, M. Fasshauer, M.R. Schön, M. Stumvoll, A.G. Beck-Sickinger, M. Blüher, Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 54, 1819–1823 (2011)
32. C. Qiu, M.A. Williams, S. Vadachkoria, I.O. Frederick, D.A. Luthy, Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet. Gynecol. 103, 519–525 (2004)
33. S. Liu, Y. Dong, T. Wang, S. Zhao, K. Yang, X. Chen, C. Zheng, Vaspin inhibited proinflammatory cytokine induced activation of nuclear factor-kappa B and its downstream molecules in human endothelial EA.hy926 cells. Diabetes Res. Clin. Pract. 103, 482–488 (2014)
34. A. Giomisi, A. Kourtis, K.A. Toulis, A.D. Anastasilakis, K.G. Makedou, M. Mouzaki, S. Gerou, E. Gavana, T. Agorastos, C. Giannoulis, Serum vaspin levels in normal pregnancy in comparison with non-pregnant women. Eur. J. Endocrinol. 164, 579–583 (2011)
35. J.G. Ray, H. Berger, L.L. Lipscombe, M. Sermer, Gestational prediabetes: a new term for early prevention? Indian J. Med. Res. 132, 251–255 (2010)
36. C. Sommer, K. Mørkrid, A.K. Jenum, L. Sletner, A. Mosdøl, K.I. Birkeland, Weight gain, total fat gain and regional fat gain during pregnancy and the association with gestational diabetes: a population-based cohort study. Int. J. Obes. (Lond). 38, 76–81 (2014)
37. A.E. Ruifrok, M.N. van Poppel, M. van Wely, E. Rogozińska, K.S. Khan, C.J. de Groot, S. Thangaratinam, B.W. Mol, Association between weight gain during pregnancy and pregnancy outcomes after dietary and lifestyle interventions: a meta-analysis. Am. J. Perinatol. 31, 353–364 (2014)
38. M.P. Malee, A. Verma, G. Messerlian, R. Tucker, B.R. Vohr, Association between maternal and child leptin levels 9 years after pregnancy complicated by gestational diabetes. Horm. Metab. Res. 34, 212–216 (2002)
39. M. Lacroix, M.C. Battista, M. Doyon, J. Ménard, J.L. Ardilouze, P. Perron, M.F. Hivert, Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 36, 1577–1583 (2013)
40. R. Retnakaran, Y. Qi, P.W. Connelly, M. Sermer, A.J. Hanley, B. Zinman, Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 53, 268–276 (2010)
41. M.M. Hedderson, J. Darbinian, P.J. Havel, C.P. Quesenberry, S. Sridhar, S. Ehrlich, A. Ferrara, Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus. Diabetes Care 36, 3930–3937 (2013)
42. M. Ballesteros, I. Simón, J. Vendrell, V. Ceperuelo-Mallafré, R.M. Miralles, G. Albaiges, F. Tinahones, A. Megia, Maternal and cord blood adiponectin multimeric forms in gestational diabetes mellitus: a prospective analysis. Diabetes Care 34, 2418–2423 (2011)
43. A. Borai, C. Livingstone, I. Kaddam, G. Ferns, Selection of the appropriate method for the assessment of insulin resistance. BMC Med. Res. Methodol. 11, 158 (2011)